ADC Therapeutics News

ADC Therapeutics | EFFECT: Others

Aug 14 06:07 ET

ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 18 21:33 ET

ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 18 21:33 ET

ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 18 21:33 ET

ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 18 21:28 ET

ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 7 17:00 ET

ADC Therapeutics | 424B5: Prospectus

May 7 16:07 ET

ADC Therapeutics | 424B5: Prospectus

May 6 06:53 ET

ADC Therapeutics | 424B3: Prospectus

Mar 15 16:18 ET

ADC Therapeutics | 424B3: Prospectus

Mar 15 16:17 ET

ADC Therapeutics | EFFECT: Others

Mar 15 06:35 ET

ADC Therapeutics | EFFECT: Others

Mar 15 06:25 ET

ADC Therapeutics | EFFECT: Others

Mar 15 06:20 ET

ADC Therapeutics | EFFECT: Others

Mar 27, 2023 00:15 ET

ADC Therapeutics | EFFECT: Others

Mar 21, 2023 00:15 ET

ADC Therapeutics | 424B7: Prospectus

Feb 2, 2023 17:01 ET

ADC Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 2, 2023 07:20 ET

ADC Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 2, 2023 06:23 ET

ADC Therapeutics | EFFECT: Others

Sep 19, 2022 00:15 ET

ADC Therapeutics | EFFECT: Others

Sep 19, 2022 00:15 ET